Finance

Beta
Lists
100700:KOSDAQ
Sewoon Medical Co Ltd
â‚©2,220.00
+2.07%
(+45.00) 1D
Jun 12, 3:30:26 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 100700...
Open
â‚©2,180
High
â‚©2,240
Low
â‚©2,180
Mkt. cap
97.24B
Avg. vol.
184.39K
Volume
0.00
Dividend
3.15%
Quarterly dividend
â‚©18
Ex-dividend date
Dec 27, 2024
P/E ratio
7.46
52-wk high
â‚©3,430
52-wk low
â‚©2,070
EPS
â‚©298
Shares outstanding
43.80M
No. of employees
172
Open
â‚©2,180
High
â‚©2,240
Low
â‚©2,180
Mkt. cap
97.24B
Avg. vol.
184.39K
Volume
0.00
Dividend
3.15%
Quarterly dividend
â‚©18
Ex-dividend date
Dec 27, 2024
P/E ratio
7.46
52-wk high
â‚©3,430
52-wk low
â‚©2,070
EPS
â‚©298
Shares outstanding
43.80M
No. of employees
172
News stories
From sources across the web
About Sewoon Medical Co Ltd
CEO-
Employees172
Founded1982
Headquarters-
SectorMedical device
Websitesewoonmedical.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.67B
16.83B
16.59B
15.39B
Cost of goods sold
10.21B
10.54B
10.13B
9.27B
Cost of revenue
10.21B
10.54B
10.13B
9.27B
Research and development expenses
134.26M
110.08M
98.77M
120.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.65B
2.19B
2.38B
2.39B
Operating expense
3.02B
2.53B
2.71B
2.74B
Total operating expenses
13.24B
13.08B
12.84B
12.01B
Operating income
2.44B
3.76B
3.75B
3.38B
Other non operating income
-101.66M
32.65M
41.49M
28.24M
EBT including unusual items
2.31B
4.67B
4.56B
4.49B
EBT excluding unusual items
2.30B
4.66B
4.55B
4.49B
Income tax expense
446.29M
818.51M
883.61M
896.74M
Effective tax rate
19.32%
17.52%
19.37%
19.98%
Other operating expenses
-
-
-
-
Net income
1.94B
3.70B
3.54B
3.43B
Net profit margin
12.39%
21.96%
21.36%
22.29%
Earnings per share
-
-
-
-
Interest and investment income
542.77M
489.24M
511.24M
535.89M
Interest expense
-9.20M
-8.28M
-7.76M
-7.28M
Net interest expenses
533.57M
480.97M
503.49M
528.61M
Depreciation and amortization charges
173.38M
171.74M
174.88M
176.62M
EBITDA
3.27B
4.54B
4.57B
4.20B
Gain or loss from assets sale
-7.27M
-9.09M
-6.35M
1.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer